1. Home
  2. WOR vs SUPN Comparison

WOR vs SUPN Comparison

Compare WOR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOR
  • SUPN
  • Stock Information
  • Founded
  • WOR 1955
  • SUPN 2005
  • Country
  • WOR United States
  • SUPN United States
  • Employees
  • WOR N/A
  • SUPN N/A
  • Industry
  • WOR Aerospace
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOR Consumer Discretionary
  • SUPN Health Care
  • Exchange
  • WOR Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • WOR 2.7B
  • SUPN 2.6B
  • IPO Year
  • WOR N/A
  • SUPN 2012
  • Fundamental
  • Price
  • WOR $55.94
  • SUPN $53.17
  • Analyst Decision
  • WOR Buy
  • SUPN Strong Buy
  • Analyst Count
  • WOR 3
  • SUPN 3
  • Target Price
  • WOR $61.00
  • SUPN $62.67
  • AVG Volume (30 Days)
  • WOR 198.2K
  • SUPN 696.0K
  • Earning Date
  • WOR 12-16-2025
  • SUPN 11-04-2025
  • Dividend Yield
  • WOR 1.36%
  • SUPN N/A
  • EPS Growth
  • WOR 179.34
  • SUPN 1411.53
  • EPS
  • WOR 2.14
  • SUPN 1.14
  • Revenue
  • WOR $1,200,161,000.00
  • SUPN $665,125,000.00
  • Revenue This Year
  • WOR $14.93
  • SUPN $7.31
  • Revenue Next Year
  • WOR $4.45
  • SUPN $21.87
  • P/E Ratio
  • WOR $26.14
  • SUPN $46.48
  • Revenue Growth
  • WOR 0.76
  • SUPN 5.55
  • 52 Week Low
  • WOR $37.88
  • SUPN $29.16
  • 52 Week High
  • WOR $70.91
  • SUPN $54.79
  • Technical
  • Relative Strength Index (RSI)
  • WOR 43.09
  • SUPN 74.78
  • Support Level
  • WOR $56.45
  • SUPN $49.95
  • Resistance Level
  • WOR $58.94
  • SUPN $54.79
  • Average True Range (ATR)
  • WOR 1.23
  • SUPN 1.49
  • MACD
  • WOR 0.29
  • SUPN 0.20
  • Stochastic Oscillator
  • WOR 27.71
  • SUPN 76.27

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: